TECHNOLOGY

Conceptually, the immune system is evolutionary optimized to target viruses with antibodies and CD8+ T cells, supported by CD4+ T cells. Using Virus-Like-Vaccines encoding endogenous retroviruses, InProTher unleashes the true potency of antiviral immunity against cancers.